Cited by 10Diabetes Management and ResearchDiabetes Treatment and ManagementDiabetes and associated disorders

Optimizing basal insulin dosing

Open access
Lal, Rayhan A., Maahs, David M.·2019·The Journal of Pediatrics

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jpeds.2019.07.030

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 12

  1. [1]Hagedorn HC, Jensen BN, Krarup NB, Wodstrup I. Landmark article Jan 18, 1936: Protamine insulinate. By H.C. Hagedorn, B.N. Jensen, N.B. Krarup, and I. Wodstrup. JAMA 1984; 251: 389– 92. 6361301
  2. [2]Hagedorn HC. Protamine insulinate: (section of therapeutics and pharmacology). Proc R Soc Med 1937; 30: 805– 14. 19991109 PMC2076399
  3. [3]Rodari T. Immunological determination of plasmatic insulin in normal subjects in basal conditions. Folia Endocrinol Mens Incretologia Incretoterapia 1960; 13: 96– 101. 14438127
  4. [4]Kruszynska YT, Home PD, Hanning I, Alberti KG. Basal and 24-h C-peptide and insulin secretion rate in normal man. Diabetologia 1987; 30: 16– 21. 3552817
  5. [5]Levy I, Recasens A, Casamitjana R, Figuerola D. Nocturnal insulin and C-peptide rhythms in normal subjects. Diabetes Care 1987; 10: 148– 51. 3556102
  6. [6]King AB, Armstrong DU. A prospective evaluation of insulin dosing recommendations in patients with type 1 diabetes at near normal glucose control: basal dosing. J Diabetes Sci Technol 2007; 1: 36– 41. 19888377 PMC2769604
  7. [7]Davidson PC, Hebblewhite HR, Steed RD, Bode BW. Analysis of guidelines for basal-bolus insulin dosing: basal insulin, correction factor, and carbohydrate-to-insulin ratio. Endocr Pract 2008; 14: 1095– 101. 19158048
  8. [8]Kuroda A, Kaneto H, Yasuda T, Matsuhisa M, Miyashita K, Fujiki N, Basal insulin requirement is ~30% of the total daily insulin dose in type 1 diabetic patients who use the insulin pump. Diabetes Care 2011; 34: 1089– 90. 21430086 PMC3114495
  9. [9]Danne T, Phillip M, Buckingham BA, Jarosz-Chobot P, Saboo B, Urakami T, ISPAD Clinical Practice Consensus Guidelines 2018: insulin treatment in children and adolescents with diabetes. Pediatr Diabetes 2018; 19(Suppl 27): 115– 35. 29999222
  10. [10]Rasmussen. J Pediatr 2019, in press.
  11. [11]Corbin KD, Driscoll KA, Pratley RE, Smith SR, Maahs DM, Mayer-Davis EJ, Obesity in type 1 diabetes: pathophysiology, clinical impact, and mechanisms. Endocr Rev 2018; 39: 629– 63. 30060120
  12. [12]Lal RA, Ekhlaspour L, Kook K, Buckingham B. Realizing a closed-loop (artificial pancreas) system for the treatment of type 1 diabetes. Endocr Rev 2019 [ Epub ahead of print]. PMC6821212 31276160

Cited by

Sorted by citations

Authors
Lal, R. A., & Maahs, D. M.
Affiliations
Stanford Medicine (US)
Corresponding author
Lal, Rayhan A.
Venue
The Journal of Pediatrics
Publisher
Elsevier BV
Published
2019-12
Volume
215
Pages
7-8
ISSN
0022-3476 (ISSN-L)
OpenAlex
W2966568588
Cited by
10
References
0
Citations by year
2025: 4 · 2024: 4 · 2023: 1 · 2021: 1
Type
journal article
Language
en
Open access
Locations
  • The Journal of Pediatrics (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Medtronic
  • Abbott Diabetes Care
  • National Institute of Diabetes and Digestive and Kidney Diseases (1K12DK122550, P30 DK116074, T32 DK007217)
  • National Institutes of Health
  • Abbott Laboratories
  • Leona M. and Harry B. Helmsley Charitable Trust
  • Roche
  • Juvenile Diabetes Research Foundation International
  • Stanford Maternal and Child Health Research Institute
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
Keywords
long-acting insulin, insulin deficiency, C-peptide, insulin secretion, immunoreactive insulin, insulin replacement therapy
MeSH terms
Child, Cross-Sectional Studies, Diabetes Mellitus, Type 1, Humans, Hypoglycemic Agents, Insulin, Registries, Body Mass Index

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review